Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
interested in candidates who want to develop an independent research profile in environmental health microbiology and who enjoy working across laboratory, field, and quantitative research. Resources
-
embryology, cardiac phenotyping, and transcriptomic and proteomic profiling. We seek a PhD or MD/PhD with a first-author publication record, mouse experience, and strong molecular biology skills; background in
-
profile, public presence, and future growth. The program is home to two centers of excellence: Olamot: Center for Scholarly and Cultural Exchange with Israel, which fosters academic and cultural exchange
-
profile, public presence, and future growth. The program is home to two centers of excellence: Olamot: Center for Scholarly and Cultural Exchange with Israel, which fosters academic and cultural exchange
-
multi-omics platforms (including proteomics, metabolomics, transcriptomics), targeted biomarker arrays, and advanced computational approaches to: Characterize biomarker profiles across kidney tissue
-
Quantum Materials and Devices – Deng Research Group Prof. Bingchen Deng (https://luddy.indiana.edu/contact/profile/index.html?bingchen_deng) in the Department of Intelligent Systems Engineering at Indiana
-
healthcare system, comprising the largest physician network in Indiana, 16 hospitals across Indiana, and a deep academic partnership with the IU School of Medicine. Ideal Candidate Profile: An established NIH
-
, and multiplex assays for protein and metabolite profiling. c. Having in-depth knowledge on genomic and transcriptomic techniques such as qPCR, RNA-Seq, and microarray for studying gene expression
-
the program’s scholarly profile, public presence, and future growth. The program is home to two centers of excellence: Olamot: Center for Scholarly and Cultural Exchange with Israel, which fosters
-
/immunology and/or large molecule biotherapeutics; Leverage metabolomics to translate metabolic profiles into insights for precision medicine and patient stratification. The goal is the application of omics